Latest News
They're not as much of a problem as some people might think.
Via The Motley Fool · May 12, 2026
Viant (DSP) Q1 2026 Earnings Call Transcript
Via The Motley Fool · May 12, 2026
United Natural Foods distributes natural, organic, and conventional groceries to a wide range of North American retailers.
Via The Motley Fool · May 12, 2026
It's a great time to "buy low."
Via The Motley Fool · May 12, 2026
Coastal Financial delivers commercial banking and BaaS solutions to businesses and fintech partners across the Puget Sound region.
Via The Motley Fool · May 12, 2026
Harmonic (HLIT) Q1 2026 Earnings Transcript
Via The Motley Fool · May 12, 2026
Millicom International Cellular (NASDAQ:TIGO) reported what management described as a solid start to 2026, with first-quarter revenue and cash flow boosted by recent acquisitions and continued growth in its core mobile business.
On the company’s earnings call, CEO Marcelo Benitez said Millicom deli
Via MarketBeat · May 12, 2026
Veritone (NASDAQ:VERI) reported lower first-quarter revenue but reaffirmed its full-year 2026 outlook, citing growing demand for its AI training data services, public sector software and recently expanded relationships with major technology companies.
On the company’s first-quarter earnings call, P
Via MarketBeat · May 12, 2026
Wise (LON:WISE) executives used an investor presentation in New York to outline the company’s growth strategy following its Nasdaq listing, emphasizing its cross-border payments infrastructure, expanding product suite and medium-term financial targets.
Founder and CEO Kristo Käärmann said Wise was
Via MarketBeat · May 12, 2026
Silvercrest Asset Management Group (NASDAQ:SAMG) reported flat first-quarter revenue and sharply lower earnings as the firm continued what management described as the most significant investment program in its history, aimed at expanding its global distribution, investment capabilities and successio
Via MarketBeat · May 12, 2026
Satellogic (NASDAQ:SATL) reported a sharp increase in first-quarter revenue and said it generated positive net cash from operating activities for the first time in its public history, as management pointed to growing demand from sovereign defense, intelligence and commercial customers.
Founder and
Via MarketBeat · May 12, 2026
SAB Biotherapeutics (NASDAQ:SABS) said its lead type 1 diabetes candidate, SAB-142, remains on track in a registrational Phase 2b trial, as the clinical-stage biopharmaceutical company reported a wider first-quarter loss alongside higher research and development spending.
Chief Executive Officer Sa
Via MarketBeat · May 12, 2026
Nayax (NASDAQ:NYAX) reported a strong start to 2026, with first-quarter revenue rising 32% year over year to approximately $107 million as the payments and commerce platform expanded its installed device base and customer count.
Co-Founder and Chief Executive Officer Yair Nechmad said the quarter r
Via MarketBeat · May 12, 2026
Supernus Pharmaceuticals delivers specialty therapies for CNS disorders, targeting healthcare providers and specialty pharmacies nationwide.
Via The Motley Fool · May 12, 2026
Amentum (AMTM) Q2 2026 Earnings Transcript
Via The Motley Fool · May 12, 2026
3D Systems (DDD) Q1 2026 Earnings Transcript
Via The Motley Fool · May 12, 2026
This fund's underperformance is testing shareholders' patience. Just understand why it's happening.
Via The Motley Fool · May 12, 2026
Alico ALCO Q2 2026 Earnings Call Transcript
Via The Motley Fool · May 12, 2026
Aramark (ARMK) Q2 2026 Earnings Transcript
Via The Motley Fool · May 12, 2026
The company reported a narrower loss than expected, while revenue missed Wall Street consensus estimates.
Via The Motley Fool · May 12, 2026
PACS (PACS) Q1 2026 Earnings Call Transcript
Via The Motley Fool · May 12, 2026
What Happened? Shares of beauty, cosmetics, and personal care retailer Ulta Beauty (NASDAQ:ULTA) fell 1.9% in the afternoon session after April CPI hit 3.8%,...
Via StockStory · May 12, 2026
Ralliant (RAL) Q1 2026 Earnings Call Transcript
Via The Motley Fool · May 12, 2026
Apple’s WWDC event could finally reset the company’s AI narrative, creating the perfect setup for another leg higher in the stock.
Via MarketBeat · May 12, 2026
Hims & Hers Health posted a Q1 FY2026 double miss, with an EPS loss of $0.40 and revenue of $608.1 million, sending shares down more than 12% after hours.
Via MarketBeat · May 12, 2026